Pages that link to "Q55471194"
Jump to navigation
Jump to search
The following pages link to Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. (Q55471194):
Displaying 50 items.
- Chemotherapy for children with medulloblastoma (Q24186770) (← links)
- Chemotherapy for children with medulloblastoma (Q24244850) (← links)
- Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors (Q26866408) (← links)
- MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma (Q27350129) (← links)
- Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy (Q28253039) (← links)
- A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer (Q28822232) (← links)
- Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. (Q30383556) (← links)
- Identification of cell surface targets through meta-analysis of microarray data (Q30558345) (← links)
- Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review (Q30764536) (← links)
- Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. (Q31151075) (← links)
- Advances in treatment of pediatric brain tumors (Q33237311) (← links)
- Carboplatin-based primary chemotherapy for infants and young children with CNS tumors (Q33384747) (← links)
- Radiation-induced adult medulloblastoma: a two-case report and review of the literature (Q33714780) (← links)
- Childhood brain tumors: epidemiology, current management and future directions (Q33970971) (← links)
- Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system (Q34008653) (← links)
- Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. (Q34108929) (← links)
- Neurocognitive outcome in survivors of pediatric cancer (Q34154933) (← links)
- Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome (Q34224760) (← links)
- Overcoming multiple drug resistance mechanisms in medulloblastoma. (Q34500602) (← links)
- Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology (Q35021335) (← links)
- Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group. (Q35058988) (← links)
- Viruses and human brain tumors: cytomegalovirus enters the fray (Q35370421) (← links)
- The molecular classification of medulloblastoma: driving the next generation clinical trials (Q35946293) (← links)
- Neurocognitive function in same-sex twins following focal radiation for medulloblastoma (Q36013355) (← links)
- Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young children (Q36028391) (← links)
- Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement (Q36048155) (← links)
- Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934. (Q36212387) (← links)
- New concepts in the treatment of brain tumors in very young children (Q36453264) (← links)
- Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma (Q36499230) (← links)
- Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy (Q36544096) (← links)
- Current treatment approaches to early childhood medulloblastoma (Q36558688) (← links)
- Emerging treatments and gene expression profiling in high-risk medulloblastoma (Q36779651) (← links)
- What is the best adjuvant treatment for very young patients with medulloblastoma? (Q36787343) (← links)
- Pediatric CNS tumors: current treatment and future directions. (Q36902043) (← links)
- Aggressive infantile embryonal tumors (Q36907570) (← links)
- M1 Medulloblastoma: high risk at any age (Q37003627) (← links)
- Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis (Q37004219) (← links)
- Medulloblastoma in childhood: new biological advances (Q37010548) (← links)
- Initial management of childhood brain tumors: neurosurgical considerations (Q37023302) (← links)
- Embryonal Central Nervous System Neoplasms Arising in Infants and Young Children: A Pediatric Brain Tumor Consortium Study (Q37119630) (← links)
- Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial (Q37151999) (← links)
- The molecular genetics of medulloblastoma: an assessment of new therapeutic targets (Q37189432) (← links)
- Medulloblastoma: what is the role of molecular genetics? (Q37202789) (← links)
- Chemotherapy for malignant brain tumors of childhood. (Q37226508) (← links)
- Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET) (Q37261835) (← links)
- Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy (Q37284324) (← links)
- Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor (Q37367443) (← links)
- Medulloblastoma in children under the age of three years: a retrospective Canadian review (Q37382230) (← links)
- Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma (Q37485279) (← links)
- Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group (Q37514290) (← links)